A norovirus vaccine based on the mRNA technology that helped to defeat Covid will be trialled in the UK for the first time, ...

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

The U.S. FDA has approved Pfizer's respiratory syncytial virus vaccine Abrysvo for individuals 18 to 59 years old that are at ...

Dr Melanie Ivarsson, chief development officer at Moderna, said: “We are delighted to bring this trial to the UK – by ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...

XEC has become the second most prevalent strain in the country, according to data released by the U.S. Centers for Disease Control and Prevention ( CDC ), representing more than 1 in 10 cases. But ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Polio is once again spreading in Pakistan, where officials say more than 1 million children missed their vaccination doses ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.